Univariate model | Multivariate model 1 | Multivariate model 2 | ||||
---|---|---|---|---|---|---|
Factor | OR (95%CI) | P value | OR (95%CI) | P value | OR (95%CI) | P value |
Age (61 ≤) | 0.3(0.2–0.8) | 0.0099* | 0.4 (0.2–0.8) | 0.06 | 0.4 (0.2–0.8) | 0.02* |
Sex (male) | 1.3 (0.6–2.9) | 0.54 | - | - | - | - |
Stage III, IV | 0.8 (0.4–1.9) | 0.68 | - | - | - | - |
Extranodal site (2 ≤) | 1.0 (0.4–2.3) | 1.00 | - | - | - | - |
LDH (> upper normal limit) | 0.5 (0.2–1.2) | 0.11 | - | - | 0.6 (0.3–1.4) | 0.24 |
Performance status (2–4) | 0.6 (0.2–1.5) | 0.24 | - | - | - | - |
IPI (high/high intermediate) | 0.4 (0.2–1.0) | 0.04* | 0.6 (0.3–1.6) | 0.33 | - | - |
Alb (3.5 mg/dl >) | 0.8 (0.5–1.4) | 0.50 | - | - | - | - |
Prophylactic G-CSF + | 1.7 (0.7–3.8) | 0.22 | - | - | - | - |